• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

    6/14/24 8:19:25 AM ET
    $ADBE
    $BITF
    $CAPT
    $CERO
    Computer Software: Prepackaged Software
    Technology
    Finance: Consumer Services
    Finance
    Get the next $ADBE alert in real time by email

    Shares of Adobe Inc. (NASDAQ:ADBE) rose sharply in today's pre-market trading following better-than-expected second-quarter earnings and strong guidance.

    Adobe reported second-quarter revenue of $5.31 billion, beating the consensus estimate of $5.292 billion. The company reported quarterly adjusted earnings of $4.48 per share, beating analyst estimates of $4.39 per share, according to data from Benzinga Pro.

    Adobe shares surged 14.6% to $525.76 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • FOXO Technologies Inc. (NYSE:FOXO) rose 53.7% to $0.3674 in pre-market trading.
    • Chijet Motor Company, Inc. (NASDAQ:CJET) shares rose 39% to $0.4030 in pre-market trading after surging 16% on Thursday.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) gained 24.5% to $0.20 in pre-market trading after dipping 17% on Thursday.
    • Vaxart, Inc. (NASDAQ:VXRT) gained 23.4% to $0.9263 in pre-market trading after the company announced a $40 million underwritten offering of 50 million common stock at $0.80 per share.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) rose 16.8% to $0.42 in pre-market trading after dipping around 49% on Thursday. The company executed pre-IND manufacturing activities for its lead therapeutic, CER-1236.
    • PainReform Ltd (NASDAQ:PRFX) shares gained 14.1% to $0.63 in pre-market trading after falling 29% on Thursday.
    • Bitfarms Ltd. (NASDAQ:BITF) shares rose 10.3% to $3.10 in pre-market trading. Riot Platforms Inc. (NASDAQ:RIOT) has upped its stake in rival Bitfarms to 14% by purchasing an additional $3.87 million worth of shares as part of its ongoing hostile takeover bid.
    • Captivision Inc. (NASDAQ:CAPT) shares rose 10.2% to $3.46 in pre-market trading after gaining 9% on Thursday.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) shares climbed 9% to $0.6674 in pre-market trading after falling over 3% on Thursday.

    Losers

    • Nexalin Technology, Inc. (NASDAQ:NXL) shares declined 29.1% to $0.9791 in pre-market trading after jumping 121% on Thursday. Nexalin Technology recently announced regulatory approval of Gen-2 15mA neurostimulation device by Brazilian Health Regulatory Agency.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) shares declined 29.1% to $1.34 in pre-market trading after the company announced pricing of $11.0 million public offering.
    • Rezolute, Inc. (NASDAQ:RZLT) shares fell 19.5% to $4.15 in pre-market trading after the company announced pricing of public offering of $60 million of common stock and pre-funded warrants.
    • Neo-Concept International Group Holdings Limited (NASDAQ:NCI) shares fell 17.2% to $0.7320 in pre-market trading after jumping over 35% on Thursday.
    • Ostin Technology Group Co Ltd (NASDAQ:OST) fell 17% to $0.41 in pre-market trading after jumping 24% on Thursday.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares fell 16.2% to $1.14 in pre-market trading after dipping 31% on Thursday.
    • Enservco Corporation (NYSE:ENSV) shares fell 11.7% to $0.1910 in pre-market trading after the company issued further update on plan to regain compliance with NYSE American Listing Standards.
    • RH (NYSE:RH) shares fell 11.6% to $244.97 in pre-market trading after the company reported mixed first-quarter financial results.
    • MSC Industrial Direct Co., Inc. (NYSE:MSM) shares declined 11.3% to $75.00 in pre-market trading after the company reported preliminary third-quarter financial results below estimates and cut its FY24 adjusted operating margin.
    • QXO, Inc. (NASDAQ:QXO) shares dipped 8.5% to $188.00 in pre-market trading after announcing a $3.5 billion private placement

    Now Read This: Over $105M Bet On This Oil Giant? Check Out These 3 Stocks Insiders Are Buying

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $BITF
    $CAPT
    $CERO

    CompanyDatePrice TargetRatingAnalyst
    MSC Industrial Direct Company Inc.
    $MSM
    2/6/2026$95.00Overweight → Neutral
    Analyst
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Adobe Inc.
    $ADBE
    1/13/2026Outperform → Perform
    Oppenheimer
    Adobe Inc.
    $ADBE
    1/12/2026$290.00Sell
    Goldman
    Adobe Inc.
    $ADBE
    1/9/2026$375.00Outperform → Market Perform
    BMO Capital Markets
    Adobe Inc.
    $ADBE
    1/5/2026$400.00Buy → Hold
    Jefferies
    Adobe Inc.
    $ADBE
    12/15/2025$310.00Sector Weight → Underweight
    KeyBanc Capital Markets
    More analyst ratings

    $ADBE
    $BITF
    $CAPT
    $CERO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MSC Industrial downgraded by Analyst with a new price target

    Analyst downgraded MSC Industrial from Overweight to Neutral and set a new price target of $95.00

    2/6/26 8:09:59 AM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Adobe downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Adobe from Overweight to Neutral and set a new price target of $330.00

    2/3/26 6:51:31 AM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    Bitfarms downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Bitfarms from Outperform to Mkt Perform and set a new price target of $3.00

    1/27/26 8:40:33 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    $ADBE
    $BITF
    $CAPT
    $CERO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Moving iMage Transforms Eight Screen Santa Fe Theater Complex for EVO Entertainment with Cutting-Edge Laser Projection and Digital Sound Systems, including an EVX Enhanced Viewing Experience Auditorium

    Santa Fe, New Mexico and Fountain Valley, California--(Newsfile Corp. - February 26, 2026) - Moving iMage Technologies, Inc. (NYSE:MITQ), a leading provider of cutting-edge out-of-home entertainment technology and services for cinema, stadiums, arenas, Esports and other venues, today announced the completion of a substantial cinema technology consultation and auditorium upgrade for EVO Entertainment's new eight-screen theater complex in Sante Fe, New Mexico. The upgraded theater complex, which is the anchor tenant within the newly renovated San Isidro Plaza, opened doors to the public on Friday, January, 23rd 2026.The project includes system design, specification and installation of laser pr

    2/26/26 7:53:00 AM ET
    $MITQ
    Industrial Machinery/Components
    Consumer Discretionary

    QXO Reports Fourth Quarter 2025 Results

    QXO, Inc. ("QXO" or the "Company") (NYSE:QXO) today issued its financial results for the fourth quarter 2025, in line with the preliminary fourth-quarter information provided during last month's common stock offering. The Company reported a GAAP basic and diluted loss per common share of $(0.17), primarily reflecting acquisition-related amortization and transaction costs, and an Adjusted Diluted Earnings per Common Share ("Adjusted Diluted EPS"), a non-GAAP financial measure, of $0.02 for the three months ended December 31, 2025. For the full year 2025, the Company reported a GAAP basic and diluted loss per common share of $(0.63) and an Adjusted Diluted EPS, a non-GAAP financial measure, o

    2/25/26 4:15:00 PM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    Bitfarms Announces Filing and Mailing of Materials for Special Meeting of Shareholders to Approve U.S. Redomiciliation Plan

    U.S. Redomiciliation is an Important Step in Bitfarms' Strategic Pivot and Rebrand as Keel InfrastructureBoard of Directors Unanimously Recommends Shareholders Vote FOR the Arrangement Resolution Voting is Now Open: Bitfarms Shareholders are Encouraged to Vote Now in Support of the U.S. Redomiciliation TORONTO, Ontario and NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American digital infrastructure and energy company, today announced that its management information circular (the "Circular") and related materials in connection with the Company's upcoming special meeting of shareholders (the "Meeting") have been filed pu

    2/24/26 5:15:00 PM ET
    $BITF
    Finance: Consumer Services
    Finance

    $ADBE
    $BITF
    $CAPT
    $CERO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hogenhuis Wladimir bought $9,548 worth of shares (5,650 units at $1.69), increasing direct ownership by 5% to 119,675 units (SEC Form 4)

    4 - Rezolute, Inc. (0001509261) (Issuer)

    12/17/25 4:14:55 PM ET
    $RZLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Roberts Brian Kenneth bought $47,600 worth of shares (28,000 units at $1.70), increasing direct ownership by 10% to 308,352 units (SEC Form 4)

    4 - Rezolute, Inc. (0001509261) (Issuer)

    12/17/25 4:13:53 PM ET
    $RZLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CFO Evans Daron bought $79,578 worth of shares (45,000 units at $1.77), increasing direct ownership by 11% to 415,900 units (SEC Form 4)

    4 - Rezolute, Inc. (0001509261) (Issuer)

    12/15/25 7:35:57 PM ET
    $RZLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $BITF
    $CAPT
    $CERO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/15/21 11:16:15 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $ADBE
    $BITF
    $CAPT
    $CERO
    SEC Filings

    View All

    SEC Form DEFA14A filed by Adobe Inc.

    DEFA14A - ADOBE INC. (0000796343) (Filer)

    2/27/26 4:07:12 PM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Adobe Inc.

    DEF 14A - ADOBE INC. (0000796343) (Filer)

    2/27/26 4:04:45 PM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by QXO Inc.

    10-K - QXO, Inc. (0001236275) (Filer)

    2/27/26 9:01:13 AM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    $ADBE
    $BITF
    $CAPT
    $CERO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Gibson John W Jr converted options into 2,161 shares and sold $586 worth of shares (715 units at $0.82), increasing direct ownership by 12% to 13,351 units (SEC Form 4)

    4 - Nauticus Robotics, Inc. (0001849820) (Issuer)

    2/24/26 6:34:15 PM ET
    $KITT
    Industrial Machinery/Components
    Industrials

    SEC Form 5 filed by Les Jason

    5 - Riot Platforms, Inc. (0001167419) (Issuer)

    2/13/26 4:17:32 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Chief Medical Officer Cummings James F. covered exercise/tax liability with 7,965 shares, decreasing direct ownership by 1% to 737,792 units (SEC Form 4)

    4 - Vaxart, Inc. (0000072444) (Issuer)

    2/5/26 6:54:11 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $BITF
    $CAPT
    $CERO
    Leadership Updates

    Live Leadership Updates

    View All

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Bitfarms Announces Board Chair Transition in Anticipation of U.S. Redomiciliation

    TORONTO, Ontario and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American energy and digital infrastructure company, today announced that Edie Hofmeister has been appointed as Chair of the Board of Bitfarms. This appointment supports Bitfarms' previously announced strategy of redomiciling to the United States. Ms. Hofmeister succeeds Brian Howlett who has served as Director since 2020, and Chairman since 2024. Mr. Howlett will continue to serve as an Independent Director. Ms. Hofmeister brings over two decades of extensive expertise in legal affairs, corporate governance, and business strategy, developed over years in

    1/14/26 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Riot Platforms Announces Chief Financial Officer Transition

    CASTLE ROCK, Colo., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or the "Company") today announced the appointment of Jason Chung as Chief Financial Officer of the Company, effective March 1, 2026. Chung succeeds Colin Yee, who has served as the Company's Chief Financial Officer since 2022. As part of this transition, Yee will continue to serve in his current capacity through March 1, 2026, after which he will transition to a Senior Advisor role to ensure a seamless transition and support the Company's strategic continuity. Chung currently serves as Riot's EVP, Head of Corporate Development & Strategy, and brings two decades of experience in investment ban

    1/2/26 5:20:00 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    $ADBE
    $BITF
    $CAPT
    $CERO
    Financials

    Live finance-specific insights

    View All

    Riot Announces Fourth Quarter and Year-End 2025 Earnings Conference Call

    CASTLE ROCK, Colo., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announced today that it has scheduled its fourth quarter and year-end 2025 earnings conference call for Monday, March 2, 2026, at 4:30 P.M. EST. This conference call will be available through an audio-only webcast. Please use this link here to register. Participants who choose to dial into the call in the United States or internationally, please use this link here to register. A replay of the webcast will be available after the call ends, through this link.About R

    2/20/26 9:00:00 AM ET
    $RIOT
    Finance: Consumer Services
    Finance

    Riot Announces Fee Simple Acquisition of Land and First Data Center Lease with AMD at the Rockdale Site

    Data center development and hyperscale leasing opportunity unlocked via fee simple acquisition of 200 acres of land underlying Riot's Rockdale SiteData center business firmly and rapidly established via execution of lease with AMD at Rockdale Site, with expected delivery beginning in January 2026 and completing in May 2026Data center portfolio of 1.7 GW of fully approved power capacity in one of the leading data center markets in the U.S. CASTLE ROCK, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, is pleased to announce a

    1/16/26 9:00:00 AM ET
    $RIOT
    Finance: Consumer Services
    Finance

    QXO Announces Fourth Quarter Summarized Preliminary Financial Information

    QXO, Inc. ("QXO" or the "Company") (NYSE:QXO) today announced the following summarized preliminary financial information. The Company expects to file its annual report on Form 10-K for the year ended December 31, 2025 on February 26, 2026. FOURTH QUARTER 2025 SUMMARY PRELIMINARY RESULTS Net sales of approximately $2.19 billion Adjusted EBITDA of approximately $150 million The Company's preliminary unaudited financial results in this press release for the fourth quarter ended December 31, 2025 are preliminary, unaudited and subject to completion, and may change as a result of management's continued review. Such preliminary results are subject to the finalization of quarter-end fin

    1/15/26 5:06:00 PM ET
    $QXO
    RETAIL: Building Materials
    Consumer Discretionary

    $ADBE
    $BITF
    $CAPT
    $CERO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy